Category: Business
Why Anthropic has edge over OpenAI in IPO race
The rivalry between Sam Altman and Dario Amodei is entering a new phase. Both AI bosses are planning public listings and hope to use the…
Apple gives developers new keys to its AI future
While the world usually tunes into Apple’s Worldwide Developers Conference (WWDC) keynote to know what’s new with the operating systems and underlying architecture that’ll define…
Maternity coverage in health insurance: What is it and what should you look for?
Welcoming a newborn baby into this world is the happiest moment for parents. However, childbirth comes at a cost. The cost should not overshadow the…
How to invest in India’s top 500 companies through 3 index funds with low cost and no overlap
Ajay’s core portfolio includes 3 schemes: a large-cap, flexi-cap, and multi-asset allocation scheme, with a small exposure to a couple of sectoral/thematic schemes. He believed…
Arbitrage MF schemes got Rs. 12,000+ crores inflows in April 2026: What are these and how have they performed?
According to AMFI data released in May 2026, the arbitrage mutual funds category received inflows of Rs. 12,378 crores in April. The inflows were higher…
Follow the PM’s Nation First call – Help the nation along with improving your personal finances
Since the start of the US-Iran War in February 2026, the prices of crude oil, fertilizers, and some other metals have spiked. The depreciation of…
The Airline Analyst Who’s Getting Paid to Watch Soccer
When the New England Patriots blocked a field goal in this year’s AFC Championship game, putting the team on the cusp of a Super Bowl…
India explores Russian coking coal assets, more nickel supplies, sources say
India‘s state-owned Steel Authority of India (SAIL) and NMDC Ltd are exploring acquisitions of coking coal assets in Russia as New Delhi seeks to secure…
Wall Street Is Rushing to Fund the AI Bonanza in Every Conceivable Way
Funding rounds and IPOs raising 11-figure sums. Blockbuster bond sales spanning three continents. The casual announcement of an $85 billion equity raise. A data center…
UK pharma giant GSK to buy US-based cancer drugmaker Nuvalent for $10.6 billion
GSK Plc agreed to buy Nuvalent Inc. in a deal valued at $10.6 billion, adding a biotech firm that’s developing treatments for lung cancer as…